Inflammatory bowel diseases
The challenging road to personalized medicine
Symposium 214, Oxford (Great Britain), March 2019
Oxford. The call for personalized medicine, currently heard louder and louder in almost all medical specialties, does not stop at inflammatory bowel diseases. Gastroenterologists hope that this will deliver highly effective and at the same time well-tolerated treatments for each patient.
more...
Future prospects for inflammatory bowel disease
Predictive medicine: Using biomarkers to predict the success of therapy
Symposium 213, Milan (Italy), October 2018
Milan. Over the past few years, the therapeutic possibilities for inflammatory bowel diseases (IBD) have expanded considerably. This trend looks set to continue in the future.
More...